首 页 | 杂志介绍 | 编委会 | 特约专家 | 期刊订阅 | 学术公告 | English
垂体促甲状腺激素腺瘤诊治进展
作者: 李晓旭、王志成、姚勇
单位:中国医学科学院 北京协和医学院 北京协和医院神经外科 北京 100730
关键词: 垂体腺瘤、促甲状腺激素、诊断、治疗
分类号:R584
出版年·卷·期(页码):2020·46·第 8 期(497-500)
摘要:
垂体促甲状腺激素腺瘤 (thyrotropin-secreting pituitary adenoma,TSH-oma)是一种起源于垂体,可以分泌促甲状腺激素(thyroid stimulating hormone,TSH)的肿瘤,仅占所有垂体腺瘤的0.5%~3%[1-2].TSH-oma是甲状腺功能亢进症的罕见原因,它通过增加TSH的分泌来刺激甲状腺激素的合成和分泌,在临床工作中误诊误治的情形时有发生.误诊会导致延误/不适当的治疗,部分患者明确诊断时肿瘤巨大且呈侵袭性生长,为治疗带来巨大挑战.因此,本文将从TSH-oma的诊治进展加以综述,以期实现临床工作者对该病正确识别,进而提高该病的诊治水平.
参考文献:

[1] 陈文立,姚顺,王梦琦,朱永红,王海军.垂体腺瘤与认知功能相关研究进展[J].中国神经精神疾病杂志,2019,(9).569-572.10.3969/j.issn.1002-0152.2019.09.013.

[2] Stephanie Kim,William P. Dillon,Thomas A. Hope,Ivan H. El-Sayed,Annemieke van Zante,Karin Wu,Umesh Masharani.Ectopic Thyroid-Stimulating Hormone\u2013Secreting Pituitary Adenoma of the Nasopharynx Diagnosed by Gallium 68 DOTATATE Positron Emission Tomography\/Computed Tomography[J].2019,400~404.10.1016/j.wneu.2019.02.022.

[3] P. Beck-Peccoz,C. Giavoli,A. Lania.A 2019 update on TSH-secreting pituitary adenomas[J].2019,(12).1401-1406.10.1007/s40618-019-01066-x.

[4] Giulia Cossu,Roy Thomas Daniel,Katarzyna Pierzchala,Moncef Berhouma,Nelly Pitteloud,Faiza Lamine,Annamaria Colao,Mahmoud Messerer.Thyrotropin-secreting pituitary adenomas: a systematic review and meta-analysis of postoperative outcomes and management[J].2019,(1).79-88.10.1007/s11102-018-0921-3.

[5] Noelia Gros Herguido,Elena Dios Fuentes,Eva Venegas-Moreno,Laura Borau Maorad,Alvaro Flores-Martinez,Pablo Remón Ruiz,Miriam Cózar Dueas,Florinda Roldán,Elena Fajardo,Eugenio Cárdenas Ruiz-Valdepeas,Ariel Kaen,Ignacio Martín Schrader,David A Cano,Alfonso Soto-Moreno.Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center.[J].2019,e634~e639.10.1016/j.wneu.2019.06.180.

[6] Marta Araujo Castro,Bryan McIver,Pablo Valderrabano.A thyrotropin-secreting pituitary adenoma treated with radiosurgery: Long-term outcomes[J].2018,(4).237-238.10.1016/j.endinu.2017.12.007.

[7] Raj K. Shrivastava,Amy Yao,Priti Balchandani.Metabolic In?Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities[J].2017,489-498.

[8] Hasegawa  Sho,Kobayashi  Noritoshi,Tokuhisa  Motohiko,Goto  Ayumu,Takano  Shoko,Takada  Yuuki,Kaneta  Tomohiro,Mori  Ryutaro,Matsuyama  Ryusei,Endo  Itaru,Yamanaka  Shoji,Nakajima  Atsushi,Inoue  Tomio,Ichikawa  Yasushi.Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors[J].2017,(1).13-20.

[9] Rotermund  Roman,Riedel  Nina,Burkhardt  Till,Matschke  Jakob,Schmidt  Nils-Ole,Aberle  Jens,Flitsch  Joerg.Surgical treatment and outcome of TSH-producing pituitary adenomas[J].2017,(7).1219-1226.

[10] Benxia  Yu,Zhongsheng  Zhang,Hao  Song,Yuchun  Chi,Chunling  Shi,Miao  Xu.Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma).[J].2017,(Spec).1947-1955.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
Copyright@2007-2016 中山大学附属第一医院(广州)期刊有限责任公司
地址:广州中山二路58号中山大学附属第一医院门诊楼13楼 邮编:510080 电话:020-87332686 87331494 EMAIL:zgsjjs@126.com
粤ICP备10090623号
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838